D.C. Mun. Regs. tit. 29, r. 29-2002
The applicant shall be a resident of the District of Columbia.
An applicant shall submit an application for assistance for eligibility determination to the ADAP, Administration for HIV Policy and Programs of the Department of Health.
The applicant shall provide, along with his or her application, written certification from a physician that the applicant has been diagnosed as having Acquired Immunodeficiency Syndrome (AIDS) or related illnesses and has been approved for treatment with the drug Retrovir (AZT), alpha interferon, aerosolized Pentamidine under current medical protocols or another eligible drug as defined in § 2099.
An applicant shall provide written consent for his or her physician to disclose the information required by § 2002.3 to the Department. The written consent shall also state that the information shall be used only for the purpose of administering this financial assistance program and shall not be disclosed to persons other than Department personnel who have a need to know for administrative purposes, unless the person to whom the information pertains gives his or her written consent.
Individuals approved for assistance under the District of Columbia Medicaid Program shall not be eligible for assistance under this program.
An individual who qualifies for assistance under this program and who has previously received Retrovir (AZT) under federally-approved clinical trials shall be given priority in the distribution of financial assistance.
D.C. Mun. Regs. tit. 29, r. 29-2002